BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Lu JC, Liu LG, Lin L, Zheng SQ, Xue Y. Incident hepatocellular carcinoma developing during tenofovir alafenamide treatment as a rescue therapy for multi-drug resistant hepatitis B virus infection: A case report and review of the literature. World J Clin Cases 2018; 6(13): 671-674 [PMID: 30430123 DOI: 10.12998/wjcc.v6.i13.671]
URL: https://www.wjgnet.com/1007-9327/full/v6/i13/671.htm
Number Citing Articles
1
Jin Li, Xiaoping Qin, Ruishan Wu, Li Wan, Liang Zhang, Rui Liu. Circular RNA circFBXO11 modulates hepatocellular carcinoma progress and oxaliplatin resistance through miR‐605/FOXO3/ABCB1 axisJournal of Cellular and Molecular Medicine 2020; 24(9): 5152 doi: 10.1111/jcmm.15162
2
Tao Xu, Yutong Zhang, Chen Wang, Huaqiang Liao, Siyuan Zhou, Dehua Li, Siying Huang, Yu Shi, Ziwen Wang, Jiao Chen, Fan-Rong Liang, Ling Zhao. Brain structural and functional differences between pure menstrual migraine and menstrually-related migraineScientific Reports 2020; 10(1) doi: 10.1038/s41598-020-73399-0
3
Ling Wei, Yongzhi Lun, Xiaoping Zhou, Shang He, Lijuan Gao, Yan Liu, Zheng He, Baoming Li, Chengbin Wang. Novel urokinase-plasminogen activator inhibitor SPINK13 inhibits growth and metastasis of hepatocellular carcinoma in vivoPharmacological Research 2019; 143: 73 doi: 10.1016/j.phrs.2019.03.009
4
Jolynne Mokaya, Anna L. McNaughton, Phillip A Bester, Dominique Goedhals, Eleanor Barnes, Brian D Marsden, Philippa C. Matthews. Hepatitis B virus resistance to tenofovir: fact or fiction? A systematic literature review and structural analysis of drug resistance mechanismsWellcome Open Research 2020; 5: 151 doi: 10.12688/wellcomeopenres.15992.1
5
Wanying Li, Rui Deng, Shi Liu, Kaifeng Wang, Jian Sun. Hepatitis B virus‐related hepatocellular carcinoma in the era of antiviral therapy: The emerging role of non‐viral risk factorsLiver International 2020; 40(10): 2316 doi: 10.1111/liv.14607